» Articles » PMID: 37942292

Multivariable Model to Predict an ACTH Stimulation Test to Diagnose Adrenal Insufficiency Using Previous Test Results

Overview
Journal J Endocr Soc
Specialty Endocrinology
Date 2023 Nov 9
PMID 37942292
Authors
Affiliations
Soon will be listed here.
Abstract

Context: The adrenocorticotropin hormone stimulation test (AST) is used to diagnose adrenal insufficiency, and is often repeated in patients when monitoring recovery of the hypothalamo-pituitary-adrenal axis.

Objective: To develop and validate a prediction model that uses previous AST results with new baseline cortisol to predict the result of a new AST.

Methods: This was a retrospective, longitudinal cohort study in patients who had undergone at least 2 ASTs, using polynomial regression with backwards variable selection, at a Tertiary UK adult endocrinology center. Model was developed from 258 paired ASTs over 5 years in 175 adults (mean age 52.4 years, SD 16.4), then validated on data from 111 patients over 1 year (51.8, 17.5) from the same center, data collected after model development. Candidate prediction variables included previous test baseline adrenocorticotropin hormone (ACTH), previous test baseline and 30-minute cortisol, days between tests, and new baseline ACTH and cortisol used with calculated cortisol/ACTH ratios to assess 8 candidate predictors. The main outcome measure was a new test cortisol measured 30 minutes after Synacthen administration.

Results: Using 258 sequential ASTs from 175 patients for model development and 111 patient tests for model validation, previous baseline cortisol, previous 30-minute cortisol and new baseline cortisol were superior at predicting new 30-minute cortisol ( = 0.71 [0.49-0.93], area under the curve [AUC] = 0.97 [0.94-1.0]) than new baseline cortisol alone ( = 0.53 [0.22-0.84], AUC = 0.88 [0.81-0.95]).

Conclusion: Results of a previous AST can be objectively combined with new early-morning cortisol to predict the results of a new AST better than new early-morning cortisol alone. An online calculator is available at https://endocrinology.shinyapps.io/sheffield_sst_calculator/ for external validation.

Citing Articles

New guidelines on glucocorticoid-induced adrenal insufficiency: the end of short synacthen test in rheumatology?.

Ornetti P, Bouillet B, Denimal D RMD Open. 2025; 11(1).

PMID: 39843354 PMC: 11759876. DOI: 10.1136/rmdopen-2024-005251.


Iatrogenic adrenal insufficiency in adults.

Martin-Grace J, Tomkins M, OReilly M, Sherlock M Nat Rev Endocrinol. 2024; 20(4):209-227.

PMID: 38272995 DOI: 10.1038/s41574-023-00929-x.

References
1.
Prete A, Bancos I . Glucocorticoid induced adrenal insufficiency. BMJ. 2021; 374:n1380. DOI: 10.1136/bmj.n1380. View

2.
Cross A, Kemp E, White A, Walker L, Meredith S, Sachdev P . International survey on high- and low-dose synacthen test and assessment of accuracy in preparing low-dose synacthen. Clin Endocrinol (Oxf). 2018; 88(5):744-751. DOI: 10.1111/cen.13559. View

3.
Morris T, White I, Carpenter J, Stanworth S, Royston P . Combining fractional polynomial model building with multiple imputation. Stat Med. 2015; 34(25):3298-317. PMC: 4871237. DOI: 10.1002/sim.6553. View

4.
Collins G, Reitsma J, Altman D, Moons K . Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement. BMC Med. 2015; 13:1. PMC: 4284921. DOI: 10.1186/s12916-014-0241-z. View

5.
Overman R, Yeh J, Deal C . Prevalence of oral glucocorticoid usage in the United States: a general population perspective. Arthritis Care Res (Hoboken). 2012; 65(2):294-8. DOI: 10.1002/acr.21796. View